Sagefield Capital’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Sagefield Capital’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,800	Closed	-$640K	–	118
2022 Q4	$640K	Buy	+17,800	New	+$445K	0.16%	75

Sagefield Capital's IMGO Position: Q1 2023 in Review

Sagefield Capital sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 17,800 shares — an estimated $640K sold.

Sagefield Capital first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $640K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Sagefield Capital reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Sagefield Capital sold 17,800 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $640K.
Sagefield Capital first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
Sagefield Capital's Imago BioSciences, Inc. Common stock position peaked at $640K in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Sagefield Capital's 13F filing for Q1 2023, filed 15 May 2023.